246 related articles for article (PubMed ID: 23161300)
1. Experience in primary hepatic neuroendocrine tumor.
Jia C; Zhang Y; Xu J; Sun K
Turk J Gastroenterol; 2012; 23(5):546-51. PubMed ID: 23161300
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment of primary hepatic neuroendocrine carcinoma].
Xu K; Chen Y; Chen M; Zhang W; Wang Y; Ji W; Wang H; Xin X; Feng J; Li Y; Yan L
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):451-5. PubMed ID: 26463150
[TBL] [Abstract][Full Text] [Related]
3. Primary hepatic neuroendocrine tumor: Five cases with different preoperative diagnoses.
Yalav O; Ülkü A; Akçam TA; Demiryürek H; Doran F
Turk J Gastroenterol; 2012 Jun; 23(3):272-8. PubMed ID: 22798119
[TBL] [Abstract][Full Text] [Related]
4. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
5. Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor.
Stoeltzing O; Loss M; Huber E; Gross V; Eilles C; Mueller-Brand J; Schlitt HJ
Langenbecks Arch Surg; 2010 Feb; 395(2):185-92. PubMed ID: 19506898
[TBL] [Abstract][Full Text] [Related]
6. Computed Tomography and Magnetic Resonance Imaging in the Diagnosis of Primary Neuroendocrine Tumors of the Liver.
Han Y; Li L; Sun H
World Neurosurg; 2020 Jun; 138():723-731. PubMed ID: 32006738
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic imaging of primary hepatic neuroendocrine tumors and treatment with transarterial chemoembolization: analysis of 6 cases].
Li XS; Zhang MC; Qu YC; Zhang XQ; Pan F; Liu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):294-297. PubMed ID: 29996342
[No Abstract] [Full Text] [Related]
8. Prognostic value of baseline volumetric multiparametric MR imaging in neuroendocrine liver metastases treated with transarterial chemoembolization.
Luo Y; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Zarghampour M; Khoshpouri P; Ameli S; Li Z; Hu D; Kamel IR
Eur Radiol; 2019 Oct; 29(10):5160-5171. PubMed ID: 30877462
[TBL] [Abstract][Full Text] [Related]
9. Update on the management of neuroendocrine hepatic metastases.
Madoff DC; Gupta S; Ahrar K; Murthy R; Yao JC
J Vasc Interv Radiol; 2006 Aug; 17(8):1235-49; quiz 1250. PubMed ID: 16923972
[TBL] [Abstract][Full Text] [Related]
10. Primary neuroendocrine carcinoma of the liver: difficult diagnosis of a rare neoplasm.
Ferrero A; Gallino C; D'Aloisio G; Gandini G; Garavoglia M
Acta Chir Belg; 1999 Dec; 99(6):299-302. PubMed ID: 10674133
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.
Park CH; Chung JW; Jang SJ; Chung MJ; Bang S; Park SW; Song SY; Chung JB; Park JY
J Gastroenterol Hepatol; 2012 Aug; 27(8):1306-11. PubMed ID: 22414232
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria.
Guo Y; Zhang Y; Huang J; Chen X; Huang W; Shan H; Zhu K
J Vasc Interv Radiol; 2016 Apr; 27(4):487-95. PubMed ID: 26922006
[TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver.
Gaur SK; Friese JL; Sadow CA; Ayyagari R; Binkert CA; Schenker MP; Kulke M; Baum R
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):566-72. PubMed ID: 21431978
[TBL] [Abstract][Full Text] [Related]
14. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
Ginsburg M; Zivin SP; Wroblewski K; Doshi T; Vasnani RJ; Van Ha TG
J Vasc Interv Radiol; 2015 Mar; 26(3):330-41. PubMed ID: 25534635
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB
AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
[TBL] [Abstract][Full Text] [Related]
16. Management of advanced neuroendocrine tumors with hepatic metastasis.
Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
[TBL] [Abstract][Full Text] [Related]
17. [Arterial embolization of hepatic metastases from neuroendocrine tumors].
Libicher M; Bovenschulte H
Radiologe; 2009 Mar; 49(3):233-41. PubMed ID: 19183927
[TBL] [Abstract][Full Text] [Related]
18. Multimodal management of neuroendocrine liver metastases.
Frilling A; Sotiropoulos GC; Li J; Kornasiewicz O; Plöckinger U
HPB (Oxford); 2010 Aug; 12(6):361-79. PubMed ID: 20662787
[TBL] [Abstract][Full Text] [Related]
19. Interventional treatment of neuroendocrine liver metastases.
Knigge U; Hansen CP; Stadil F
Surgeon; 2008 Aug; 6(4):232-9. PubMed ID: 18697366
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.
Takaki H; Yamakado K; Sakurai H; Nakatsuka A; Shiraki K; Isaji S; Takeda K
AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]